Pfizer Commences $5 Billion Accelerated Share Repurchase

Pfizer Inc. (NYSE:PFE) today announced that it has entered into an accelerated share repurchase agreement with Goldman, Sachs & Co. (GS&Co.) to repurchase $5 billion of Pfizer’s common stock. This agreement is part of Pfizer’s existing share repurchase authorization under which an additional $11 billion of authority was announced in October 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC